Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Curr Hypertens Rep. 2014 Apr;16(4):424. doi: 10.1007/s11906-014-0424-1

Table 1.

Evidence supporting a role for immune system activation in human
hypertension
Reference(s)
Restoration of T cell counts in patients with HIV increases the prevalence of hypertension 77
Anti-kidney antibodies are present in the sera of hypertensive patients 6
Immunosuppressive therapy lowers blood pressure in hypertensive patients 22, 23
Proinflammatory cytokines/mediators positively correlate with blood pressure 10, 11, 18, 78, 79
Circulating CD8+ T cells are increased in hypertensive patients 79
Renal lymphocyte infiltration is increased in patients with hypertension 80, 81
Circulating heat shock proteins, known immune modulators, are increased in hypertensive patients 82, 83
Circulating autoantibodies are increased in patients with essential hypertension, refractory hypertension, and preeclampsia 5760, 63, 84
Immunoadsorption of pathogenic autoantibodies lowers blood pressure in hypertensive patients 60
The prevalence of hypertension is increased in patients with immune-mediated diseases (i.e., systemic lupus, rheumatoid arthritis, psoriasis, scleroderma). 46, 49, 85, 86